Course Description |
|
Course Name |
: |
Clinical Pharmacology 1 |
|
Course Code |
: |
FAR520 |
|
Course Type |
: |
Optional |
|
Level of Course |
: |
Second Cycle |
|
Year of Study |
: |
1 |
|
Course Semester |
: |
Fall and Spring (16 Weeks) |
|
ECTS |
: |
4 |
|
Name of Lecturer(s) |
: |
Prof.Dr. YUSUF KARATAŞ Prof.Dr. CEMİL GÖÇMEN |
|
Learning Outcomes of the Course |
: |
knows the identification of ethical principles in clinical research Knows how to prescribe Gains the basic concepts of clinical pharmacology Knows the Principles of Good Clinical Practice
knows how to identify bioavailability and bioequivalence studies
|
|
Mode of Delivery |
: |
Face-to-Face |
|
Prerequisites and Co-Prerequisites |
: |
None |
|
Recommended Optional Programme Components |
: |
None |
|
Aim(s) of Course |
: |
To learn the principles of clinical use of drugs used in therapy and research, rational drug use, clinical trials, phase studies and prescribing |
|
Course Contents |
: |
This course includes rational drug use, phase studies and prescribing |
|
Language of Instruction |
: |
Turkish |
|
Work Place |
: |
Seminar room |
|
|
Course Outline /Schedule (Weekly) Planned Learning Activities |
| Week | Subject | Student's Preliminary Work | Learning Activities and Teaching Methods |
|
1 |
The ways of finding new medications |
reads relevant sources |
presentation-interactive discussion |
|
2 |
Pre-Clinical Review |
reads relevant sources |
presentation-interactive discussion |
|
3 |
The Ethical aspects of clinical trial |
reads relevant sources |
presentation-interactive discussion |
|
4 |
Good clinical practice |
reads relevant sources |
presentation-interactive discussion |
|
5 |
Various aspects of clinical drug trials |
reads relevant sources |
presentation-interactive discussion |
|
6 |
Interventional studies |
reads relevant sources |
presentation-interactive discussion |
|
7 |
Observational studies |
reads relevant sources |
presentation-interactive discussion |
|
8 |
Mid term exam |
reads relevant sources |
presentation-interactive discussion |
|
9 |
Data types, analysis and equivalence trials |
reads relevant sources |
presentation-interactive discussion |
|
10 |
Pharmacovigilance |
reads relevant sources |
presentation-interactive discussion |
|
11 |
Analysis of pharmacoeconomy |
reads relevant sources |
presentation-interactive discussion |
|
12 |
Drug utilization studies |
Reading resource |
presentation-interactive discussion |
|
13 |
Bioavailability of drugs |
Reading resource |
presentation-interactive discussion |
|
14 |
Bioequivalence |
reads relevant sources |
presentation-interactive discussion |
|
15 |
Drug Scheme on European Union |
reads relevant sources |
presentation-interactive discussion |
|
16/17 |
Final exam |
reads relevant sources |
oral-written exam |
|
|
| Contribution of the Course to Key Learning Outcomes |
| # | Key Learning Outcome | Contribution* |
|
1 |
Students gain the ability to research on the areas like preventing irrational drug use detecting the problems due to drug use |
5 |
|
2 |
Students gain basic pharmacological information |
5 |
|
3 |
Students have the ability to take on the responsibilities of pharmacology |
5 |
|
4 |
Students know the experimental research techniques in pharmacology |
5 |
|
5 |
Students gain the ability to present their knowledge in an academic environment |
5 |
|
6 |
Students have an ability to access scientific information |
5 |
|
7 |
Students are informed about pharmacovigilance |
5 |
|
8 |
Students have the ability to apply the basic principles of rational drug use on daily practice |
5 |
|
9 |
Students gain the ability to take place in the in vitro/ in vivo animal experiments |
4 |
|
10 |
Students gain the ability to plan and conduct experimental pharmacological projects and analyze the experimental results. |
4 |
|
11 |
Students gain the ability to follow present literature in the field of pharmacology |
5 |
|
12 |
Students guide the assistant health personnel to receive pharmacology education |
5 |
|
13 |
Students are informed about rational drug use |
5 |
|
14 |
Students know the pharmacological research areas |
5 |
| * Contribution levels are between 0 (not) and 5 (maximum). |
|
|